Biogen targets $15.25-$16.25 EPS for 2025 amid LEQEMBI growth and cost savings Biogen targets $15.25-$16.25 EPS for 2025 amid LEQEMBI growth and cost savings Post ContentbiibRead More You might also be interested in reading IGM Biosciences climbs on merger deal with Concentra. February 12, 2025 In Mainstream ← Previous post Next post →